Disclosure of voting results and Scrutinizers report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Limited conducted a postal ballot (e-voting) that concluded on August 2, 2025, where shareholders approved a resolution to increase the company's Authorised Share Capital and amend the Capital Clause of the Memorandum of Association. Out of 19,893,889 total outstanding shares, 6,261,107 shares (31.47%) were voted, with 99.81% in favour and just 0.19% against. Promoters voted fully in favour (5,345,000 shares, 100%), and public non-institutions also backed the resolution overwhelmingly (98.72% in favour). The resolution was declared passed with the requisite majority by the scrutinizer, CS Vinay Babu Gade.
This is a procedural step that simply raises the company's authorised capital ceiling, giving the board future flexibility to issue new shares (for fundraising, acquisitions, bonus, or splits). It does not cause any immediate dilution or change in shareholding for existing investors, but signals that the company is preparing optionality for a future capital action.